Patient time and out-of-pocket costs for long-term prostate cancer survivors in Ontario, Canada

Journal of Cancer Survivorship

Volumn 8, Issue 1, 2014, Pages 9-20

  de Oliveira, Claire ^a,b   Bremner, Karen E ^b,c   Ni, Andy ^d   Alibhai, Shabbir M H ^b,c,e,f   Laporte, Audrey ^b,f   Krahn, Murray D ^b,c,e,f,g  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c TORONTO GENERAL HOSPITAL   (Canada)

^d University of North Carolina at Chapel Hill   (United States)

^e UNIVERSITY OF TORONTO   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

^g UNIVERSITY OF TORONTO   (Canada)

Author keywords

Out of pocket costs; Prostatic neoplasm; Survivorship; Time costs

Indexed keywords

ANTIANDROGEN; ANTINEOPLASTIC AGENT;

ADENOCARCINOMA; AGE; AGED; ARTICLE; CANADA; COST; COST OF ILLNESS; ECONOMICS; ENTEROPATHY; ERECTILE DYSFUNCTION; HEALTH CARE COST; HUMAN; INCOME; INSURANCE; MALE; MICTURITION DISORDER; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; NEOPLASM; POSTOPERATIVE COMPLICATION; PROSTATE TUMOR; PROSTATECTOMY; RADIATION INJURY; RETIREMENT; STATISTICS; SURVIVOR;

ADENOCARCINOMA; AGE FACTORS; AGED; ANDROGEN ANTAGONISTS; ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; COST OF ILLNESS; COSTS AND COST ANALYSIS; ERECTILE DYSFUNCTION; HEALTH EXPENDITURES; HUMANS; INCOME; INSURANCE COVERAGE; INTESTINAL DISEASES; MALE; MIDDLE AGED; NEOPLASMS, HORMONE-DEPENDENT; ONTARIO; POSTOPERATIVE COMPLICATIONS; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIATION INJURIES; RETIREMENT; SURVIVORS; URINATION DISORDERS;

EID: 84897578641     PISSN: 19322259     EISSN: 19322267     Source Type: Journal    
DOI: 10.1007/s11764-013-0305-7     Document Type: Article

References (28)

1. Longo CJ, Fitch M, Deber RB, Williams AP. Financial and family burden associated with cancer treatment in Ontario, Canada. Support Care Cancer. 2006;14: 1077-85.
2. Longo CJ, Deber R, Fitch M, Williams P, DeSouza D. An examination of cancer patients' monthly "out-of-pocket" costs in Ontario. Eur J Cancer Care. 2007;16: 500-7.
3. Federico CA, Hsu PC, Krajden M, Yoshida EM, Bremner KE, Weiss AA, et al. Patient time costs and out-of-pocket costs in hepatitis C. Liver Int. 2012;32(5): 815-25.
4. Mathews M, West R, Buehler S. How important are out-of-pocket costs to rural patients' cancer care decisions? Can J Rural Med. 2009;14(2): 54-60.
5. Langa KM, Fendrick AM, Chernew ME, Kabeto MU, Paisley KL, Hayman JA. Out-of-pocket health-care expenditures among older Americans with cancer. Value Health. 2004;7(2): 186-94.
6. Yabroff KR, Warren JL, Knopf K, Davis WW, Brown ML. Estimating patient time costs associated with colorectal cancer care. Med Care. 2005;43(7): 640-8.
7. Yabroff KR, Kim Y. Time costs associated with informal care giving for cancer survivors. Cancer. 2009;115(18 Suppl): 4362-73.
8. Huang J, Zhou S, Groome P, Tyldesley S, Zhang-Solomans J, Mackillop WJ. Factors affecting the use of palliative radiotherapy in Ontario. J Clin Oncol. 2001;19(1): 137-44.
9. Ferlay J, Shin H-R, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12): 2893-917.
10. Krahn MD, Zagorski B, Laporte A, Alibhai SMH, Bremner KE, Tomlinson G, et al. Healthcare costs associated with prostate cancer: estimates from a population-based study. Br J Urol Int. 2010;105(3): 338-40.
11. Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF. Overview of the SEER-medicare data. Content, research applications, and generalizability to the United States elderly population. Med Care. 2002;40(8, Supplement): IV-3-18.
12. Hall S, Schulze K, Groome P, McKillop W, Holowaty E. Using cancer registry data for survival studies: the example of the Ontario cancer registry. J Clin Epidemiol. 2006;59: 67-76.
13. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis. 1987;40: 373-83.
14. Litwin MS, Hays RD, Fink A, et al. The UCLA prostate cancer index: development, reliability, and validity of a health-related quality of life measure. Med Care. 1998;36: 1002-12.
15. van Buuren S, Oudshoorn CGM. Flexible multivariate imputation by MICE. Leiden: TNO Preventie en Gezondheid, TNO/VGZ/PG 99. 054, 1999.
16. Sterne JA, White IR, Carlin JB, Spratt M, Royston P, Kenward MG, et al. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. Br Med J. 2009;338: b2393.
17. Jones AM, Rice N, Bago d'Uva T, Balia S. Applied health economics. London: Routledge; 2007.
18. R Development Core Team. R: a language and environment for statistical computing. R Foundation for Statistical Computing Vienna, Austria.
19. SAS Inc. SAS 9. 1. 3 for Windows. Cary, N. C., USA.
20. Krahn M, Bremner KE, Tomlinson G, Ritvo P, Irvine J, Naglie G. Responsiveness of disease-specific and generic utility instruments in prostate cancer patients. Qualily Life Res. 2007;16: 509-22.
21. Krahn MD, Ritvo P, Irvine J, Tomlinson G, Bremner KE, Bezjak A, et al. Patient and community preferences for outcomes in prostate cancer: implications for clinical policy. Med Care. 2003;41: 153-64.
22. Pisu M, Azuero A, McNees P, Burkhardt J, Benz R, Meneses K. The out of pocket cost of breast cancer survivors: a review. J Cancer Survivorship. 2010;4(3): 202-9.
23. Jayadevappa R, Schwartz JS, Chhatre S, Gallo JJ, Wein AJ, Malkowicz SB. The burden of out-of-pocket and indirect costs of prostate cancer. Prostate. 2010;70(11): 1255-64.
24. Taylor AKL, Luta G, Miller AB, Church TR, Kelly SP, Muenz LR, et al. Long-term disease-specific functioning among prostate cancer survivors and noncancer controls in the prostate, lung, colorectal, and ovarian cancer screening trial. J Clin Oncol. 2012;30(22): 2768-75.
25. Krahn MD, Bremner KE, Alibhai SMH, Ni A, Tomlinson G, Laporte A, Naglie G. A reference set of health utilities for long-term survivors of prostate cancer: population-based data from Ontario, Canada. Quality of Life Research. 2013. doi: 10. 1177/0272989X13493970.
26. Yabroff KR, Lawrence WF, Clauser S, Davis WW, Brown ML. Burden of illness in cancer survivors: findings from a population-based national sample. J Natl Cancer Inst. 2004;96(17): 1322-30.
27. Mickevičienė A, Vanagas G, Ulys A, Jievaltas M, Smailytė G, Padaiga Ž. Factors affecting health-related quality of life in prostate cancer patients. Scan J Urol Nephrol. 2012;46(3): 180-7.
28. Lauzier S, Maunsell E, Drolet M, Coyle D, Hébert-Croteau N. Validity of information obtained from a method for estimating cancer costs from the perspective of patients and caregivers. Qual Life Res. 2010;19(2): 177-89.